Literature DB >> 8733522

Are calcium antagonists safe in hypertension?

G Y Lip, D G Beevers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8733522      PMCID： PMC2398440          DOI： 10.1136/pgmj.72.846.193

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  9 in total

1.  Nifedipine and mortality. Grave defects in the dossier.

Authors:  L H Opie; F H Messerli
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

Review 2.  Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease.

Authors:  R Collins; S MacMahon
Journal:  Br Med Bull       Date:  1994-04       Impact factor: 4.291

3.  Are calcium antagonists safe?

Authors:  F H Messerli
Journal:  Lancet       Date:  1995-09-16       Impact factor: 79.321

4.  Apparatchiks of science share their anxiety.

Authors:  D S Greenberg
Journal:  Lancet       Date:  1995-09-09       Impact factor: 79.321

5.  Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

Authors:  P H Held; S Yusuf; C D Furberg
Journal:  BMJ       Date:  1989-11-11

6.  Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.

Authors:  C D Furberg; B M Psaty; J V Meyer
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

7.  Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society.

Authors:  P Sever; G Beevers; C Bulpitt; A Lever; L Ramsay; J Reid; J Swales
Journal:  BMJ       Date:  1993-04-10

8.  Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group.

Authors:  R E Goldstein; S J Boccuzzi; D Cruess; S Nattel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

9.  The risk of myocardial infarction associated with antihypertensive drug therapies.

Authors:  B M Psaty; S R Heckbert; T D Koepsell; D S Siscovick; T E Raghunathan; N S Weiss; F R Rosendaal; R N Lemaitre; N L Smith; P W Wahl
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.